药明康德:出售药明合联5080万股股票 投资收益约为人民币18.47亿元

人民财讯
02 Apr

  人民财讯4月2日电,药明康德(603259)4月2日晚间公告,2025年4月1日,公司通过大宗交易继续出售所持有的药明合联5080万股股票,约占药明合联当前总股本的4.23%,成交金额约21.78亿港元(不包含手续费等交易费用),占公司最近一期(2024年度)经审计归属母公司股东净资产的3.43%。经公司财务部门按中国企业会计准则初步核算,本次出售药明合联股票的投资收益约为人民币18.47亿元,占公司最近一期(2024年度)经审计归属母公司股东净利润的比例超过10%,影响公司2025年上半年净利润约为人民币18.47亿元。

(文章来源:人民财讯)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10